Luminai raised $38 million in Series B funding to scale its AI platform that automates healthcare administrative workflows. The company is working with Cleveland Clinic to expand the use of its system across high-volume processes, starting with referral management. The post Luminai Raises $38M With Cleveland Clinic Using Its AI for Hospital Operations appeared first on MedCity News.

Cigna Healthcare ranks highest in digital experience among commercial plans, while UPMC Health Plan ranks highest among Medicare Advantage plans, according to a new JD Power report. The post Which Health Plans Rank Highest In Digital Experience? appeared first on MedCity News.

Gilead Sciences exercised its option license a Kymera Therapeutics’ protein-degrading drug designed to eliminate the cancer-driving protein CDK2. Meanwhile, Roche’s new partnership with C4 Therapeutics is focused on developing degrader antibody drug conjugates for undisclosed cancer targets. The post Gilead and Roche Bet on Protein Degraders for Their Cancer Drug Pipelines appeared first on MedCity News.

To give patients the care they deserve and improve healthcare’s return on investment, PCPs can harness intelligent, clinically fluent AI – not to replace or override physicians or give them what tech companies think they need, but to support them in pragmatic ways. The post AI-Driven Precision Care is the Fix for Our Health System’s Failures appeared first on MedCity News.

This is not a debate about care models or physician preferences. It is a contest over who will control the referral pathways and the revenue streams that originate at the front door of healthcare. The post The Quiet Battle for the Front Door of Healthcare appeared first on MedCity News.

[Sponsored] A new eBook explores how using real world data from patients can help drug developers improve outcomes for non-small cell lung cancer and other patient populations. The post How to Use Real-World Data to Improve Drug Development, Starting with the Patient Journey appeared first on MedCity News.

Health insurers have reduced prior authorizations by 11% and are continuing reforms to streamline and speed up approvals, according to an announcement from AHIP and Blue Cross Blue Shield Association. The post Insurers have Cut Prior Auth by 11% Following Commitments appeared first on MedCity News.

Insmed drug Brinsupri failed to beat a placebo in a mid-stage clinical trial testing the daily pill as a treatment for hidradenitis suppurativa, a chronic inflammatory skin disorder. Brinsupri is still projected to become a blockbuster seller in non-cystic fibrosis bronchiectasis, where it is the first approved therapy for this chronic lung condition. The post Trial Failure in the Skin Does Not Dent Insmed Drug’s Potential in the Lungs appeared first on MedCity News.

Jefferson Health in Philadelphia is suing Aetna over a new Medicare Advantage payment policy that hospitals say unfairly reduces reimbursements for legitimate inpatient stays. The case highlights a broader clash between providers and Medicare Advantage plans over “downcoding” short hospital stays and controlling costs. The post Jefferson Health Sues Aetna As Providers’ Frustration with MA Grows appeared first on MedCity News.

Rural health organizations cannot afford to get dazzled by AI demo candy. There is no such thing as “FixHealthcareGPT,” and investing in the wrong technology for the future isn’t going to do anything to improve patient outcomes today. The post Rural Healthcare Transformation Has to Focus on the Real World, Not Techno-Fantasies appeared first on MedCity News.

Consumers are inundated with false information circulating online about GLP-1 medicines, which causes confusion and can lead to potentially serious health problems resulting from dosing errors and adverse reactions to ingredients in compounded GLP-1 products. The post It’s Time to Put Guardrails on GLP-1 Compounding appeared first on MedCity News.

[Sponsored] Enterprise EHR boosts scalability, interoperability, and governance for large healthcare systems. The post The Power Behind Enterprise EHR Software for Large Healthcare Systems  appeared first on MedCity News.

Healthcare leaders can’t tell whether value-based care and Medicare Advantage are truly lowering costs. Some see promise in these models and ongoing innovations, while others say the programs haven’t delivered measurable savings and point to direct contracting as a more transparent way to control spending. The post Do Healthcare CEOs Agree on Whether VBC and MA Actually Save Money? appeared first on MedCity News.

Gilead Sciences’ Tubulis acquisition brings antibody drug conjugates in clinical development for cancer. Analysts say the Tubulis platform technologies that yielded these ADCs could also help Gilead develop drugs in other therapeutic areas. The post Gilead’s Pipeline Strategy Takes Shape With $3B Acquisition of Cancer Biotech Tubulis appeared first on MedCity News.

When revenue cycle partners wait to be asked, or rely on “tell us what you need” as a default, they miss critical opportunities to deliver meaningful performance, support their client organizations, and ultimately serve patients better. In today’s healthcare environment, partnership requires anticipation, not reaction. The post Stop Waiting to Be Asked: What Operators Really Need From Their Revenue Cycle Partners appeared first on MedCity News.